New Director to Enhance European Industry Coverage from London

LONDON – 27 January 2022 Baird, an employee-owned, international financial services firm, announced today that Tom Cowap has joined the firm’s Global Investment Banking business as Director in its Global Healthcare Investment Banking team. He is based in London and is working closely with Andrew Nicholson and Baird’s rapidly expanding global healthcare team. Cowap’s primary coverage area is pharmaceutical services and he will be working closely with Adam Huitt and Nick Bell, to expand Baird’s global pharmaceutical services practice.

Cowap joins Baird from Alantra where he spent the last nine years building Alantra’s pharma services coverage effort, providing M&A services for financial sponsors and independently-owned, founder backed businesses in the space. He has advised on a number of notable recent M&A transactions, including: Five Arrow’s investment in Integrated Drug Discovery Services provider Sygnature Discovery, Synova Capital’s investment in preclinical CRO Charnwood Molecular and NorthEdge’s investment in Helios Medical Communications. Prior to Alantra, Cowap worked at PricewaterhouseCoopers in their Financial Due Diligence Team. He also served in the British Army (Reserve – 7th Battalion, The Rifles and 4th Battalion, The Yorkshire Regiment). Cowap is an ACA and has a bachelor’s degree in finance from Durham University.

“We are thrilled that Tom has joined our team,” said Rob Andrews, Co-Head of Baird Global Healthcare Investment Banking. “Tom’s deep pharma services expertise and significant transaction experience with a broad group of healthcare companies and investors will continue to accelerate the seismic growth in our global healthcare business, which has more than tripled in size in the last three years. His relationships in the sector both enhance and complement Baird’s existing coverage.”

Bill Suddath, Co-Head of Baird Global Healthcare Investment Banking, added: “Baird has a long and successful track record in the pharma services sector. The addition of Tom will strengthen further our rapidly growing European healthcare coverage and cross-border pharma services capabilities.”

“I’m delighted to be joining Baird’s fast-growing healthcare team,” said Cowap “The team’s credentials in Pharma Services and Pharma Tech, combined with the firm’s impressive U.S. pedigree make it a great platform to support clients within the Pharma and Life Science ecosystem globally. I’m particularly excited to put this to work for European clients to support their trans-Atlantic growth plans.”

Baird’s Global Healthcare platform includes over 40 investment bankers, who have completed over 200 healthcare M&A and financing transactions since 2017; 10 Equity Research Analysts covering nearly 140 healthcare stocks; and a dedicated Equity Sales & Trading team. Baird continues to host its annual Global Healthcare Conference. Although in a virtual format again this past year, the conference featured more than 135 presenting companies, 1,300+ attendees and 1,900+ one-on-one meetings.

About Baird Global Investment Banking

Baird is a leading global investment bank focused on the middle market with c.350 investment banking professionals in the U.S., Europe and Asia. Baird provides corporations, entrepreneurs, private equity and venture capital firms with in-depth market knowledge and extensive experience in mergers and acquisitions, debt advisory and equity financing transactions. Since 2015, Baird has completed almost 580 advisory transactions, representing more than $167 billion in transaction value, and nearly 360 financings, raising more than $112 billion.

About Baird

Putting clients first since 1919, Baird is an employee-owned, international wealth management, asset management, investment banking/capital markets, and private equity firm with offices in the United States, Europe and Asia. Baird has approximately 4,600 associates serving the needs of individual, corporate, institutional and municipal clients and more than $355 billion in client assets as of December 31, 2020. Committed to being a great workplace, Baird ranked No. 32 on the 2021 Fortune 100 Best Companies to Work For® list. – its 18th consecutive year on the list. Baird is the marketing name of Baird Financial Group. Baird’s principal operating subsidiaries are Robert W. Baird & Co. Incorporated in the United States and Robert W. Baird Group Ltd. in Europe. Baird also has an operating subsidiary in Asia supporting Baird’s investment banking and private equity operations. For more information, please visit Baird’s website at

For additional information, please contact:

Baird Public Relations –